Citius Pharmaceuticals, Inc. (CTXR) Social Stream
CITIUS PHARMACEUTICALS INC (CTXR) Price Targets From Analysts
Use the tables below to see what analysts covering CITIUS PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-06 | 2 | $10 | $4 | $7 | $0.741 | 844.67% |
| 2022-01-03 | 3 | $10 | $4 | $6 | $0.741 | 709.72% |
| 2022-12-23 | 3 | $10 | $6 | $8 | $0.741 | 979.62% |
| 2023-04-25 | 3 | $10 | $4 | $6.666 | $0.741 | 799.6% |
| 2023-06-21 | 3 | $8 | $4 | $6 | $0.741 | 709.72% |
| 2023-11-02 | 3 | $8 | $4 | $5.333 | $0.741 | 619.7% |
The Trend in the Analyst Price Target
CTXR's average price target has moved down $1.33 over the prior 45 weeks.
Over the past 36 weeks, CTXR's average upside potential has been 469.21%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-29 | 3 | 10 | 4 | 6.666 | 1.100 | 506% |
| 2023-04-25 | 3 | 10 | 4 | 6.666 | 1.430 | 366.15% |
| 2023-05-04 | 3 | 8 | 4 | 6.000 | 1.250 | 380% |
| 2023-08-01 | 3 | 8 | 4 | 5.333 | 0.955 | 458.43% |
| 2023-10-24 | 3 | 8 | 4 | 5.333 | 0.791 | 574.21% |
CTXR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
CTXR's average broker recommendation rating improved by 0 over the prior 14 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTXR as an investment opportunity.
- In terms of how CITIUS PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 673.54% of that group.
- CITIUS PHARMACEUTICALS INC's average analyst price target is greater than 42.81% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, CITIUS PHARMACEUTICALS INC's number of analysts covering the stock is higher than 46.92% of them.
- CITIUS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -422.48% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CITIUS PHARMACEUTICALS INC are ABEO, ACIU, and SYRS.
View All Top Stocks by Price Target
What is the outlook for CTXR? Use POWR Ratings for clearer insight into price direction.